Summary
The U.S. Food and Drug Administration (FDA) has approved another generic version of the abortion pill mifepristone made by Evita Solutions, leading to criticism from anti-abortion groups and some politicians. The pill is used to end pregnancies up to 10 weeks and has been considered safe by the FDA since its first approval in 2000. Despite the new approval, access to mifepristone remains limited in many parts of the U.S. due to state laws.
Key Facts
- The FDA approved a generic version of the abortion pill mifepristone from Evita Solutions.
- Mifepristone, paired with misoprostol, is used to terminate pregnancies through 10 weeks.
- Anti-abortion groups and some politicians have criticized the FDA's approval.
- The FDA approved the first version of mifepristone in 2000 and the first generic in 2019.
- In 2021, under President Biden, the FDA allowed the pill to be prescribed online and shipped by mail.
- Access to the drug is limited by state laws in many U.S. regions that restrict or ban abortion.
- The drug is involved in ongoing legal challenges related to its use restrictions.
- Major medical groups do not support restrictions on mifepristone.
